Assessment of the gonadotrophin–gonadal axis in androgen insensitivity syndrome
- aDepartment of Paediatrics, University of Cambridge Clinical School, Box 116, Addenbrookes Hospital, Hills Road, Cambridge CB2 2QQ, UK, bDepartment of Paediatrics, Princess Margaret Hospital, Lai Chi Kok, Kowloon, Hong Kong
- Dr Ahmed. email:
- Accepted 19 October 1998
OBJECTIVE To study the value of measuring serum luteinising hormone (LH), follicle stimulating hormone (FSH), testosterone, and dihydrotestosterone (DHT) in androgen insensitivity syndrome (AIS).
DESIGN Retrospective study of patients on a nationwide register of AIS.
PATIENTS Sixty one cases of AIS with androgen receptor (AR) dysfunction (abnormalities of the AR gene and/or abnormal AR binding) were divided into three age groups: infants, < 1 year old; children, 1–13 years old; and postpubertal, > 13 years old.
MEASUREMENTS Age, dose of human chorionic gonadotrophin (hCG) stimulation, pre-hCG and post-hCG serum testosterone values, serum DHT values, and serum LH and FSH values before and after LH releasing hormone (LHRH) stimulation.
RESULTS In 23 of 30 infants testosterone was within age related reference ranges; six were above this range. The median testosterone rise following variable dosage of hCG was 9.5 times the basal value. The increment was not related to the hCG dose, age, or basal concentration of testosterone. The median basal and stimulated testosterone:DHT ratios were 2.5 and 6.1, respectively. The median increment in DHT was 2.2-fold. Seventeen of 18 FSH and 11 of 19 LH measurements were within age related ranges in infants; in seven patients LH values were above the range. LHRH stimulation performed in 39 patients showed an exaggerated LH in all age groups. The FSH response was not exaggerated in children.
CONCLUSION Although a positive hCG test excludes biosynthetic defects of testosterone, an inadequate response does not exclude AIS. Basal LH and testosterone may not be raised during early infancy. An LHRH stimulation test might be useful for evaluating cases of suspected AIS presenting in mid-childhood.
Androgen insensitivity syndrome (AIS) is the largest single entity that leads to male under-masculinisation
The diagnosis of AIS requires thorough exclusion of defects of testosterone biosynthesis and metabolism
The hypothalamo–pituitary–gonadal axis is intrinsically active during the 1st month of life and this is an opportune time to investigate affected children
Although adequate serum concentrations of testosterone exclude a defect in testosterone biosynthesis, a low testosterone value at baseline or following human chorionic gonadotrophin stimulation does not always exclude AIS
Baseline luteinising hormone concentrations are not necessarily inappropriately high in AIS; a luteinising hormone releasing hormone stimulation test might be a useful investigation in later childhood